PEG vs REGN
Public Service Enterprise Group Inc (PEG) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Public Service Enterprise Group Inc (PEG) is a utilities - regulated electric company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PEG revenue for 2024-12-31 was $10.29B. Net income was $1.77B. Revenue was down 8.4% from 2023-12-31 to 2024-12-31. PEG currently screens at market cap $39.57B and trailing P/E 17.6.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PEG currently screens at market cap $39.57B and trailing P/E 17.6. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PEG and REGN stock pages for the full models.
Not investment advice.